Emmes Revenue and Competitors

Location

$2.7M

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Emmes's estimated annual revenue is currently $189M per year.(i)
  • Emmes's estimated revenue per employee is $145,860
  • Emmes's total funding is $2.7M.

Employee Data

  • Emmes has 1296 Employees.(i)
  • Emmes grew their employee count by -7% last year.

Emmes's People

NameTitleEmail/Phone
1
Associate VPReveal Email/Phone
2
Associate VP, Software DevelopmentReveal Email/Phone
3
VPReveal Email/Phone
4
Associate VPReveal Email/Phone
5
Associate VP, Medical Director, EuropeReveal Email/Phone
6
VPReveal Email/Phone
7
Associate VP, Human ResourcesReveal Email/Phone
8
Executive Assistant to VPReveal Email/Phone
9
Associate VP, Clinical Trial Management and MonitoringReveal Email/Phone
10
VP, Financial Planning & AnalysisReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.9M77N/AN/AN/A
#2
$557.1M39015%N/AN/A
#3
$4M49-6%N/AN/A
#4
$3.8M467%N/AN/A
#5
$2.6M35N/AN/AN/A
#6
$21M187N/AN/AN/A
#7
$2.1M29-19%N/AN/A
#8
$279.6M1958N/AN/AN/A
#9
$67.1M5265%N/AN/A
#10
$706.1M4945N/AN/AN/A
Add Company

What Is Emmes?

Emmes offers services as a professional partner to clinicians, scientists, and program leaders. For 40 years, our staff of over 600 experienced professionals has provided the full range of Contract Research Organization expertise necessary to conduct clinical research with a firm scientific basis that is fully compliant with national and international regulatory guidelines. A collaboration with Emmes is your assurance of excellence in the important issues of public health.

keywords:N/A

$2.7M

Total Funding

1296

Number of Employees

$189M

Revenue (est)

-7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Emmes News

2022-03-30 - Emmes Acquires CRO Institut Dr. Schauerte

Emmes Acquires CRO Institut Dr. Schauerte. Full-service, technology-oriented CRO specializes in late-phase, non-interventional, and post-market...

2022-03-22 - Emmes Acquires CRO Casimir

Emmes, a global, full-service Clinical Research Organization (CRO), has acquired Casimir, a U.S.-based CRO. Casimir has experience in more...

2022-03-22 - PE-backed Emmes buys Casmir

Emmes, which is backed by Behrman Capital, has acquired Plymouth, Massachusetts-based Casmir, a clinical research organization.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$367.9M13018%N/A
#2
$611.4M1506N/AN/A
#3
$315.5M15542%N/A
#4
$596.9M157910%N/A
#5
$978.1M19613%$11M